UBS AM’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
SCM
UBS AM's EIKN Position: Q3 2026 in Review
UBS AM opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 130 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #4119 among its holdings.
75 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- UBS AM held 130 shares of Eikon Therapeutics worth $1.04K as of Q3 2026.
- Eikon Therapeutics was a new UBS AM position in Q3 2026.
- Eikon Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4119 holding.
- 75 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.